Ayradia (metronidazole oral suspension) has been approved for the treatment of Giardia duodenalis infection in dogs. Ayradia is the first FDA-approved treatment for Giardia duodenalis for any animal species.
<the> approval means there is an approved product for dogs that has known safety and effectiveness for this species and is manufactured to quality standards.”
Source: FDA, October 11, 2023. Link. Ayradia is administered orally at 25 mg/kg (11.3 mg/lb) of body weight, using the supplied syringe, twice daily for five consecutive days.
Ayradia is sponsored by Virbac AH, Inc.